cladribine has been researched along with Aggressive Systemic Mastocytosis in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (41.38) | 29.6817 |
| 2010's | 14 (48.28) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Brand, T; Cross, NCP; Fabarius, A; Hofmann, WK; Horny, HP; Kreil, S; Lübke, J; Metzgeroth, G; Naumann, N; Reiter, A; Schwaab, J; Sotlar, K; Valent, P | 1 |
| Barete, S; Bielle, F; Guillaume-Jugnot, P; Maillart, E; Shor, N; Zavanone, C | 1 |
| Mannelli, F | 1 |
| Pardanani, A | 5 |
| Metzgeroth, G; Reiter, A; Schwaab, J | 1 |
| Lock, AD; McNamara, CJ; Rustin, MH | 1 |
| Broijl, A; Hermans, MA; van Daele, PL | 1 |
| Aichberger, KJ; Gleixner, KV; Kretschmer, A; Sperr, WR; Valent, P | 1 |
| Eccersley, LR; Hoffbrand, AV; McNamara, CJ; Rustin, MH | 1 |
| Butterfield, JH; Li, CY; Lim, KH; Pardanani, A; Tefferi, A | 1 |
| Gotlib, J | 1 |
| Pardanani, A; Tefferi, A | 2 |
| Blatt, K; Böhm, A; Gleixner, KV; Herrmann, H; Pehamberger, H; Peter, B; Pickl, WF; Rabitsch, W; Schernthaner, GH; Schuch, K; Sonneck, K; Sperr, WR; Valent, P | 1 |
| Colović, M; Colović, N; Radojković, M; Ristić, S; Terzić, T | 1 |
| Geissler, P; Shnawa, P; Sperr, WR; Valent, P; Wimazal, F | 1 |
| Bennett, M; Chubar, Y | 1 |
| Maniu, CM; Ribi, C; Spertini, F | 1 |
| Fijnheer, R; Gerrits, WB; Kluin-Nelemans, HC; Oldhoff, JM; Pasmans, SG; Van 't Wout, JW; van Dobbenburgh, OA; Van Doormaal, JJ; Verhoef, G | 1 |
| Barete, S; Bonté, I; Casassus, P; de Gennes, C; Fain, O; Hermine, O; Lortholary, O; Marrache, F; Mémain, N | 1 |
| Tefferi, A | 1 |
| Landthaler, M; Meyer, S; Schleyer, V; Szeimies, RM | 1 |
| Cortes, J; Faderl, S; Ferrajoli, A; Garcia-Manero, G; Giles, F; Hennessy, B; Kantarjian, H; O'brien, S; Ossa, G; Verstovsek, S | 1 |
| Kanz, L; Sökler, M | 1 |
| Barete, S; Casassus, P; Eclache, V; Fain, O; Hermine, O; Lorholary, O; Stirnemann, J | 1 |
12 review(s) available for cladribine and Aggressive Systemic Mastocytosis
| Article | Year |
|---|---|
Catching the clinical and biological diversity for an appropriate therapeutic approach in systemic mastocytosis.
Topics: Cladribine; Humans; Interferons; Mast Cells; Mastocytosis, Systemic; Proto-Oncogene Proteins c-kit | 2021 |
Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Bone Marrow; Cladribine; Disease Management; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Interferon-alpha; Interleukin-2 Receptor alpha Subunit; Mast Cells; Mastocytosis, Systemic; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Risk Assessment; Staurosporine; Survival Analysis; Transplantation, Homologous; Tryptases | 2019 |
Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
Topics: Adrenal Cortex Hormones; Adult; Benzamides; Bone Marrow; CD2 Antigens; Cladribine; Disease Progression; Humans; Imatinib Mesylate; Interferon-alpha; Interleukin-2 Receptor alpha Subunit; Mast Cells; Mastocytosis, Systemic; Mutation; Palliative Care; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Risk Factors; Tryptases | 2013 |
[Systemic mastocytosis].
Topics: Biopsy, Needle; Bone Marrow; Cladribine; DNA Mutational Analysis; Humans; Interferon-alpha; Mastocytosis, Systemic; Prognosis; Proto-Oncogene Proteins c-kit; Staurosporine | 2014 |
Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Benzamides; Bone Marrow; Cell Proliferation; Cladribine; Disease Management; Humans; Imatinib Mesylate; Interferon-alpha; Mast Cells; Mastocytosis, Systemic; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Risk Factors; Severity of Illness Index; Tryptases | 2015 |
Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.
Topics: Cladribine; Humans; Interferon-alpha; Mastocytosis, Systemic; Mutation; Prognosis; Proto-Oncogene Proteins c-kit; Treatment Outcome | 2010 |
Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.
Topics: Adrenal Cortex Hormones; Adult; Bone Marrow Examination; Cell Lineage; Cladribine; Clinical Trials as Topic; Clone Cells; Disease Management; Disease Progression; Humans; Hydroxyurea; Immunophenotyping; Interferon-alpha; Leukemia, Mast-Cell; Mast Cells; Mastocytosis, Systemic; Mutation, Missense; Organ Specificity; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Risk Assessment; Staurosporine; Tryptases | 2012 |
[Systemic mastocytosis--new therapeutic strategies].
Topics: Allergy and Immunology; Anti-Inflammatory Agents; Cladribine; Humans; Interferon alpha-2; Interferon-alpha; Mastocytosis, Systemic; Medical Oncology; Protein Kinase Inhibitors; Recombinant Proteins; Therapies, Investigational | 2013 |
[Treatment of systemic mastocytosis].
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Benzamides; Cladribine; Cytarabine; Diphosphonates; Enzyme Inhibitors; Histamine H1 Antagonists; Humans; Imatinib Mesylate; Interferon-alpha; Mastocytosis, Systemic; Photochemotherapy; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines | 2003 |
Clinical, genetic, and therapeutic insights into systemic mast cell disease.
Topics: Adult; Benzamides; Cladribine; Humans; Imatinib Mesylate; Mast Cells; Mastocytosis; Mastocytosis, Systemic; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha | 2004 |
Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cladribine; Combined Modality Therapy; Cytarabine; Female; Humans; Idarubicin; Imatinib Mesylate; Interferon-alpha; Leukemia, Myeloid, Acute; Male; Mastocytosis, Systemic; Middle Aged; Myelodysplastic Syndromes; Piperazines; Prospective Studies; Pyrimidines; Stem Cell Transplantation; Treatment Outcome | 2004 |
[Systemic mastocytosis].
Topics: Benzamides; Biomarkers; Bone and Bones; Cell Differentiation; Cell Division; Cladribine; Diphosphonates; Flushing; Histamine H1 Antagonists; Histamine Release; Imatinib Mesylate; Interferon-alpha; Leukotriene Antagonists; Mast Cells; Mastocytosis, Systemic; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Prognosis; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Serine Endopeptidases; Stem Cell Factor; Tachycardia; Tryptases | 2005 |
1 trial(s) available for cladribine and Aggressive Systemic Mastocytosis
| Article | Year |
|---|---|
Cladribine therapy for systemic mastocytosis.
Topics: Adult; Aged; Antimetabolites; Biomarkers; Cladribine; Drug Eruptions; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mastocytosis, Systemic; Middle Aged; Myelodysplastic Syndromes; Treatment Outcome | 2003 |
16 other study(ies) available for cladribine and Aggressive Systemic Mastocytosis
| Article | Year |
|---|---|
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis.
Topics: Cladribine; Humans; Leukemia, Mast-Cell; Mastocytosis, Systemic; Prognosis; Registries | 2023 |
Atypical multiple sclerosis associated with indolent systemic mastocytosis treated by cladribine.
Topics: Cladribine; Humans; Immunosuppressive Agents; Mastocytosis, Systemic; Multiple Sclerosis | 2023 |
Sustained improvement in urticaria pigmentosa and pruritus in a case of indolent systemic mastocytosis treated with cladribine.
Topics: Cladribine; Female; Humans; Immunosuppressive Agents; Mastocytosis, Systemic; Middle Aged; Pruritus; Treatment Outcome; Urticaria Pigmentosa | 2015 |
A unique presentation of pulmonary disease in advanced systemic mastocytosis, proven by the presence of mast cells in bronchoalveolar lavage: a case report.
Topics: Adult; Anemia; Anti-Inflammatory Agents; Antineoplastic Agents; Bronchoalveolar Lavage; Cladribine; Down Syndrome; Fatal Outcome; Female; Humans; Leukemoid Reaction; Lung Diseases; Mastocytosis, Systemic; Prednisolone; Sepsis | 2016 |
Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis.
Topics: Aged; Antineoplastic Agents; Cladribine; Dasatinib; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Leukemia, Mast-Cell; Mastocytosis, Systemic; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Treatment Failure; Tryptases | 2008 |
Paraneoplastic pemphigus associated with systemic mastocytosis.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cladribine; Disease Progression; Fatal Outcome; Humans; Immunoglobulins, Intravenous; Liver; Male; Mastocytosis, Systemic; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Pentostatin; Prednisone; Pyrimidines; Rituximab; Treatment Failure; Urticaria Pigmentosa | 2009 |
Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Bone Marrow; Cladribine; Dioxygenases; DNA Mutational Analysis; DNA-Binding Proteins; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Imatinib Mesylate; Interferon-alpha; Janus Kinase 2; Male; Mast Cells; Mastocytosis, Systemic; Middle Aged; Mutation, Missense; Piperazines; Point Mutation; Prednisone; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit; Pyrimidines; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
On being metachromatic: mystique and misunderstanding in mastocytosis.
Topics: Benzamides; Cell Shape; Cladribine; Cytoplasmic Granules; Humans; Hydroxyurea; Imatinib Mesylate; Interferon-alpha; Mast Cells; Mastocytosis, Systemic; Piperazines; Pyrimidines; Retrospective Studies; Staining and Labeling | 2009 |
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V.
Topics: Adult; Aged; Amino Acid Substitution; Antineoplastic Agents; Apoptosis; Benzamides; Caspases; Cell Line, Tumor; Cladribine; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Male; Mast Cells; Mastocytosis, Systemic; Middle Aged; Mutation, Missense; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Tryptases | 2010 |
Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management.
Topics: Adult; Antineoplastic Agents; Benzamides; Bone Marrow; Cladribine; Dasatinib; Disease-Free Survival; Humans; Hydroxyurea; Imatinib Mesylate; Interferon Type I; Mast Cells; Mastocytosis, Systemic; Piperazines; Point Mutation; Proto-Oncogene Proteins c-kit; Pyrimidines; Recombinant Proteins; Risk; Staurosporine; Thiazoles | 2011 |
Response to cladribine in patient with systemic mastocytosis.
Topics: Adult; Cladribine; Female; Humans; Immunosuppressive Agents; Mastocytosis, Systemic; Remission Induction | 2011 |
Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Antimetabolites; Child; Cladribine; Female; Humans; Male; Mastocytosis, Systemic; Middle Aged; Prevalence; Severity of Illness Index | 2012 |
Response of urticaria pigmentosa to cladribine in a patient with systemic mastocytosis.
Topics: Antineoplastic Agents; Cladribine; Fractures, Spontaneous; Humans; Humeral Fractures; Humeral Head; Male; Mastocytosis, Systemic; Middle Aged; Osteoporosis; Urticaria Pigmentosa | 2013 |
Treatment of systemic mast cell disease: beyond interferon.
Topics: Antimetabolites; Benzamides; Cladribine; Drug Evaluation; Humans; Imatinib Mesylate; Interferon-alpha; Mastocytosis, Systemic; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Pilot Projects; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha | 2004 |
["Smoldering systemic mastocytosis. "Successful therapy with cladribine].
Topics: Antineoplastic Agents; Biopsy; Cladribine; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Mastocytosis, Systemic; Middle Aged; Skin; Treatment Outcome | 2004 |
[Systemic mastocytosis].
Topics: Anti-Inflammatory Agents; Benzamides; Cladribine; Humans; Imatinib Mesylate; Immunosuppressive Agents; Interferon-alpha; Male; Mastocytosis, Systemic; Middle Aged; Piperazines; Prednisolone; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines | 2005 |